エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/31 | 2,938 | 2,970 | 2,846 | 2,951 | -11 | -0.4% | 16,800 |
2024/01/30 | 2,953 | 2,993 | 2,950 | 2,962 | +11 | +0.4% | 11,800 |
2024/01/29 | 2,954 | 2,963 | 2,935 | 2,951 | -3 | -0.1% | 4,300 |
2024/01/26 | 2,929 | 2,989 | 2,917 | 2,954 | +25 | +0.9% | 12,900 |
2024/01/25 | 2,940 | 2,943 | 2,849 | 2,929 | +12 | +0.4% | 13,000 |
2024/01/24 | 2,860 | 2,918 | 2,848 | 2,917 | +57 | +2% | 7,900 |
2024/01/23 | 2,945 | 2,945 | 2,860 | 2,860 | -60 | -2.1% | 14,100 |
2024/01/22 | 2,836 | 2,932 | 2,821 | 2,920 | +117 | +4.2% | 23,200 |
2024/01/19 | 2,808 | 2,810 | 2,760 | 2,803 | +41 | +1.5% | 15,200 |
2024/01/18 | 2,772 | 2,792 | 2,736 | 2,762 | +10 | +0.4% | 13,200 |
2024/01/17 | 2,766 | 2,829 | 2,723 | 2,752 | +21 | +0.8% | 31,500 |
2024/01/16 | 2,825 | 2,840 | 2,721 | 2,731 | -93 | -3.3% | 19,400 |
2024/01/15 | 2,791 | 2,844 | 2,772 | 2,824 | +13 | +0.5% | 11,200 |
2024/01/12 | 2,871 | 2,882 | 2,760 | 2,811 | -89 | -3.1% | 23,000 |
2024/01/11 | 2,887 | 2,903 | 2,859 | 2,900 | +18 | +0.6% | 16,200 |
2024/01/10 | 2,894 | 2,908 | 2,873 | 2,882 | -12 | -0.4% | 9,000 |
2024/01/09 | 2,864 | 2,925 | 2,864 | 2,894 | +39 | +1.4% | 15,500 |
2024/01/05 | 2,989 | 2,989 | 2,854 | 2,855 | -139 | -4.6% | 23,400 |
2024/01/04 | 2,932 | 3,010 | 2,880 | 2,994 | +102 | +3.5% | 19,400 |
2023/12/29 | 2,961 | 2,966 | 2,861 | 2,892 | -45 | -1.5% | 15,200 |
2023/12/28 | 2,900 | 2,943 | 2,864 | 2,937 | +23 | +0.8% | 11,300 |
2023/12/27 | 2,890 | 2,917 | 2,870 | 2,914 | +43 | +1.5% | 17,200 |
2023/12/26 | 2,823 | 2,884 | 2,823 | 2,871 | +48 | +1.7% | 12,400 |
2023/12/25 | 2,822 | 2,830 | 2,785 | 2,823 | +10 | +0.4% | 14,400 |
2023/12/22 | 2,848 | 2,866 | 2,791 | 2,813 | -35 | -1.2% | 12,900 |
2023/12/21 | 2,851 | 2,907 | 2,836 | 2,848 | -53 | -1.8% | 14,200 |
2023/12/20 | 2,927 | 2,952 | 2,867 | 2,901 | -26 | -0.9% | 22,100 |
2023/12/19 | 2,876 | 2,976 | 2,876 | 2,927 | +78 | +2.7% | 33,100 |
2023/12/18 | 2,725 | 2,862 | 2,720 | 2,849 | +115 | +4.2% | 28,900 |
2023/12/15 | 2,669 | 2,750 | 2,669 | 2,734 | +65 | +2.4% | 26,300 |
2023/12/14 | 2,710 | 2,723 | 2,635 | 2,669 | -29 | -1.1% | 37,700 |
2023/12/13 | 2,761 | 2,778 | 2,698 | 2,698 | -48 | -1.7% | 43,700 |
2023/12/12 | 2,843 | 2,866 | 2,740 | 2,746 | -67 | -2.4% | 30,100 |
2023/12/11 | 2,844 | 2,861 | 2,770 | 2,813 | -8 | -0.3% | 32,700 |
2023/12/08 | 2,890 | 2,923 | 2,805 | 2,821 | -102 | -3.5% | 51,200 |
2023/12/07 | 3,040 | 3,050 | 2,903 | 2,923 | -217 | -6.9% | 64,900 |
2023/12/06 | 3,090 | 3,140 | 3,040 | 3,140 | +45 | +1.5% | 41,400 |
2023/12/05 | 3,360 | 3,405 | 3,095 | 3,095 | -265 | -7.9% | 53,000 |
2023/12/04 | 3,775 | 3,825 | 3,355 | 3,360 | -430 | -11.3% | 88,900 |
2023/12/01 | 3,915 | 3,950 | 3,780 | 3,790 | -95 | -2.4% | 31,500 |
2023/11/30 | 3,790 | 3,930 | 3,765 | 3,885 | +95 | +2.5% | 42,100 |
2023/11/29 | 3,760 | 3,890 | 3,740 | 3,790 | +50 | +1.3% | 39,800 |
2023/11/28 | 3,645 | 3,760 | 3,640 | 3,740 | +95 | +2.6% | 25,900 |
2023/11/27 | 3,650 | 3,755 | 3,640 | 3,645 | -5 | -0.1% | 30,100 |
2023/11/24 | 3,700 | 3,780 | 3,645 | 3,650 | -50 | -1.4% | 22,600 |
2023/11/22 | 3,615 | 3,740 | 3,615 | 3,700 | +55 | +1.5% | 21,200 |
2023/11/21 | 3,650 | 3,755 | 3,595 | 3,645 | +75 | +2.1% | 38,000 |
2023/11/20 | 3,550 | 3,690 | 3,495 | 3,570 | +50 | +1.4% | 37,900 |
2023/11/17 | 3,470 | 3,560 | 3,470 | 3,520 | +20 | +0.6% | 26,400 |
2023/11/16 | 3,505 | 3,650 | 3,465 | 3,500 | -5 | -0.1% | 36,800 |
201~
250
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム